Assessment of global risk: a foundation for a new, better definition of hypertension [0.03%]
全球风险评估：建立高血压新定义的良好基础
Thomas D Giles
Thomas D Giles
The prevalence of individuals with increased blood pressure (BP) is growing. A greater understanding of the various pathogenetic mechanisms of hypertension and associated BP increases would provide a better strategy for preventing and treat...
Michael J Bloch,Jan Basile
Michael J Bloch
Thomas G Pickering
Thomas G Pickering
Joel Handler
Joel Handler
Stanley S Franklin
Stanley S Franklin
There is overwhelming evidence that pharmacologic treatment of isolated systolic hypertension (ISH) (systolic blood pressure >or=140 mm Hg and diastolic blood pressure or=140 mm Hg in general and >or=130 mm Hg in persons with diabetes or ch...
Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived [0.03%]
血尿酸作为心血管和肾脏疾病风险因素的研究：一个老生常谈话题的复兴
Francesca Viazzi,Giovanna Leoncini,Elena Ratto et al.
Francesca Viazzi et al.
Hyperuricemia is commonly associated with traditional risk factors such as abnormalities in glucose metabolism, dyslipidemia, and hypertension. Recent studies have revived the controversy over the role of serum uric acid as an independent p...
Atherosclerotic renal artery stenosis and renovascular hypertension: clinical diagnosis and indications for revascularization [0.03%]
动脉粥样硬化肾动脉狭窄和肾血管性高血压的临床诊断及血运重建指征
Edmund Kenneth Kerut,Stephen A Geraci,Chester Falterman et al.
Edmund Kenneth Kerut et al.
Atherosclerotic renal artery stenosis (RAS) is relatively common and often associated with reversible hypertension, progressive renal insufficiency, and/or coronary-independent pulmonary edema. Not all RAS is associated with renovascular hy...
Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol [0.03%]
用于治疗脂质异常的烟酸缓释剂/他汀类药物组合疗法：低高密度脂蛋白胆固醇患者中的应用聚焦
Steven G Chrysant,Mohammed Ibrahim
Steven G Chrysant
Statins are effective drugs for lowering low-density lipoprotein cholesterol, and their use has been associated with a significant decrease in cardiovascular morbidity and mortality. However, statins are ineffective in lowering plasma trigl...
Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy [0.03%]
血管紧张素Ⅱ受体拮抗剂逆转左心室肥厚的机制研究
Sverre E Kjeldsen,Arne Strand,Stevo Julius et al.
Sverre E Kjeldsen et al.
Left ventricular hypertrophy refers to a pathologic increase in left ventricular mass and is associated with an increased risk of subsequent cardiovascular morbidity and mortality from any cause. In the development of left ventricular hyper...